TABLE 2.

Treatment regimen

Group	Intervention	Frequency (no. of daily doses)	Daily dose
A	Untreated control at the start of treatment (day 28)
B	Untreated control at the end of treatment (day 57)
C	Oral ETO and DCS at human equivalent dose for 4 weeks	20	4.7 mg ETO + 2.35 mg DCS
D	Inhaled ETO and DCS for 4 weeks	20	70 μg ETO + 35 μg DCS
E	Oral ETO and DCS at inhalation-equivalent dose for 4 weeks	20	70 μg ETO +35 μg DCS
F	Inhaled + oral to achieve human equivalent dose	20	4.63 mg ETO + 2.31 mg DCS (oral); 70 μg ETO +35 μg DCS (inhalation)